1. Gupta R. Trends in hypertension epidemiology in India. J Human Hypertension 2004;18:73-8. [DOI via Crossref] [Pubmed] |
|
2. Roberts CK, Vaziri ND, Wang XQ, Barnad JR. Enhanced NO inactivation and hypertension induced by a high fat, refined-carbohydrate diet. Hypertension 2000;36:423-9. [DOI via Crossref] [Pubmed] |
|
3. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46. [DOI via Crossref] |
|
4. Silva BR, Pernomian L, Bendhack LM. Contribution of oxidative stress to endothelial dysfunction in hypertension. Front Physiol 2012;3:441. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
5. Stocker R, Keaney JF Jr. Role of oxidative modifi-cations in atherosclerosis. Physiol Rev 2004;84:1381-478. [DOI via Crossref] [Pubmed] |
|
6. Touyza RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999;34:976-82. [DOI via Crossref] |
|
7. Chrissobolis S, Didion S, Kinzenbaw DA, Schrader LI, Dayal S, Lentz SR, et al. Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 2008;51:872-7. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
8. Ebrahimian T, Touyz RM. Thioredoxin in vascular biology: role, in hypertension. Antioxidants Redox Signaling 2008;10:1127-36. [DOI via Crossref] [Pubmed] |
|
9. Wilcox CS, Pearlman A. Chemistry and antihypertensive, effects of tempol and other nitroxides. Pharmacol Rev 2008;60:418-69. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
10. Tandon R, Sihna MK, Garg AH, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005;18(6):297 - 9. [Pubmed] |
|
11. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-74. [DOI via Crossref] |
|
12. Aebi HE. Catalase invitro. Meth Enzymol 1984;105:121-6. [DOI via Crossref] |
|
13. Paglia DE, Valentine WN. Studies on the quantitative characterization of erythrocyte glutathione peroxidase. J lab Clin Med 1967;70:158-68. [Pubmed] |
|
14. Philpot J. Assay for MDA levels. Rad Res 1963;3:55-80. [DOI via Crossref] |
|
15. Valko M, Leibfritz D. Free radicals and oxidants in normal physiological functions and human disease. Int J Biochem cell Biol 2007;39:44-84. [DOI via Crossref] [Pubmed] |
|
16. Halliwell B. Biochemistry of oxidative stress. Biochem Sac Trans 2007;35:1147-50. [DOI via Crossref] [Pubmed] |
|
17. Meera KS, Marcus SR. Endothelial dysfunction and oxidative stress in hypertension. Asian J Med Res 2012;1: 84-9. |
|
18. Nwanjo HU, Oze G, Okafor MC, Nwasu D, Nwankpa P. Oxidative stress and non enzymatic antioxidant status in hypertensive patients in Nigeria. African journal of Biotechnology 2007;6:1681-4. |
|
19. Sierra A, Larrousse M. Endothelial dysfunction is associated with increased level of biomarkers in essential hypertension. J Hum Hypertens 2010;24:373-9. [DOI via Crossref] [Pubmed] |
|
20. Simic DV, Mimikoka J, Pljesa EM, Savic RA, Opacic M, Matic D, et al. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 2006;20:149-55. [DOI via Crossref] [Pubmed] |
|
21. Sozmen B, Kazaz C, Taskiran D, Tuzun S, Sozmen EY. Effect of N-dicyclopropyimethyl- amino-2-oxazoline(S-3341) on antioxidant status and nitric oxide in hypertensive patients. Curr Med Res Opin 1998;14:89-96. [DOI via Crossref] [Pubmed] |
|
22. Vasdev S, Gill VD, Singal PK. Modulation of oxidative stress- induced changes in hypertension and atherosclerosis by antioxidants. ExptClinCardiol 2006;11:206-16. |
|
23. Armas PMC, Armas HMJ, Sara CB, Cammarata R, Pancheo B, Guerreo J, et al. Nitric oxide and malondialdehyde in human hypertension. Am J Ther 2007;14:172-6. [DOI via Crossref] [Pubmed] |
|
24. Griendling KK, Miniere CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular and smooth muscle cells. CircResc 1994;74:1141-8. |
|
25. Williams B, Lacy PS, Thom SM. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of conduit artery function evolution study. Circulation 2006;113:1213-25. [DOI via Crossref] [Pubmed] |
|
26. Ferrori P, Fox K. Insight into the mode of action of ACE inhibition in coronary artery disease: The ultimate EUROPA story. Drugs 2009;69:265-77. [DOI via Crossref] [Pubmed] |
|
27. Kim MK, Sasaki S, Saszuki S, Okubo S, Hayashi M, Tsugane S. Lack of long term effect of vit C supplementation on blood pressure. Hypertension 2002;40:797-803. [DOI via Crossref] [Pubmed] |
|
28. Palumbo G, Avanzini F, Alli E, Roncoglioni MC, Ronchi E, Capra A, et al. Effect of vit E on clinic and ambulatory blood pressure in treated hypertensive patients: Collaborative group of the primary prevention project-hypertension study. Am J Hypertens 2000;13:564-7. [DOI via Crossref] |
|